권민석 (아주대학교병원 종양혈액내과, 삼성서울병원 혈액종양내과)님 | 한빛사연구자 > 한빛사

아주대학교병원 종양혈액내과, 삼성서울병원 혈액종양내과

최종업데이트 2024.08.14.

Clinical application of whole-genome sequencing of solid tumors for precision oncology
- Exp. Mol. Med., 13 August 2024 | https://doi.org/10.1038/s12276-024-01288-x
- 2024-08
- 한빛사논문
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer
- J. Immunother. Cancer, Online issue publication July 05, 2022 | http://dx.doi.org/10.1136/jitc-2022-005041
- 2022-07
- 의약학
- 한빛사논문
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD1 therapy
- Ann. Oncol., Available online 25 October 2021 | https://doi.org/10.1016/j.annonc.2021.10.009
- 2021-10
- 의약학
- 한빛사논문
Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer
- Cancer Discov., April 12, 2021 | https://doi.org/10.1158/2159-8290.CD-21-0219
- 2021-04
- 의약학
- 한빛사논문

연구자 ID

저자논문